Exhibit 10.15
CONSENT TO SUBLEASE
This Consent to Sublease (this “Consent”) is made as of June 8, 2022, by 601 & 651 GATEWAY CENTER LP, a Delaware limited partnership, having an address of 26 North Euclid Avenue, Pasadena, California 91101, Attn: Corporate Secretary, Re: 601/651 Gateway (“Landlord”), ICON CLINICAL RESEARCH, LLC, a Delaware limited liability company, having an address of 601 Gateway Boulevard, Suite 1250, South San Francisco, CA 94080, Attn: Lease Administrator (“Tenant”), and CORTEXYME, INC., a Delaware corporation, having an address of 601 Gateway Boulevard, Suite 1250, South San Francisco, CA 94080, Attn: Legal Department (“Sublessee”) with reference to the following Recitals.
R E C I T A L S
NOW, THEREFORE, in consideration of the foregoing and the agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Landlord hereby consents to the sublease of the Subleased Premises to Sublessee, such consent being subject to and upon the following terms and conditions to which Tenant and Sublessee hereby agree:
(a) all of the covenants, agreements, terms, provisions and conditions contained in the Lease, (b) superior ground leases, mortgages, deeds of trust, or any other hypothecation
or security now existing or hereafter placed upon the real property of which the Premises are a part and to any and all advances secured thereby and to all renewals, modifications, consolidations, replacements and extensions thereof, and (c) all matters of record affecting the Premises and all laws, ordinances and regulations now or hereafter affecting the Premises.
Tenant shall remain liable and responsible for the due keeping, performance and observance of all the terms, covenants and conditions set forth in the Lease on the part of the Tenant to be kept, performed and observed and for the payment of the annual rent, additional rent and all other sums now and hereafter becoming payable thereunder for all of the Premises, including, without limitation, the Subleased Premises.
[ Signatures on next page ]
IN WITNESS WHEREOF, Landlord, Tenant and Sublessee have caused their duly authorized representatives to execute this Consent as of the date first above written.
LANDLORD:
601 & 651 GATEWAY CENTER LP,
a Delaware limited partnership
By: GATEWAY CENTER GP LLC,
a Delaware limited liability company, general partner
By: GATEWAY PORTFOLIO MEMBER LLC,
a Delaware limited liability company, managing member
By: GATEWAY PORTFOLIO HOLDINGS LLC,
a Delaware limited liability company, managing member
By: ARE-SAN FRANCISCO NO. 83, LLC,
a Delaware limited liability company, managing member
By: ALEXANDRIA REAL ESTATE EQUITIES, L.P.,
a Delaware limited partnership, managing member
By: ARE-QRS CORP.,
a Maryland corporation, general partner
By: Kristen Childs
Its: Vice President - Real Estate
TENANT: ICON CLINICAL RESEARCH LLC,
a Delaware limited liability company
By:George McMillan
Its: EVP, Chief Commercial Officer
I hereby certify that the signature, name, and title above
are my signature, name and title
SUBLESSEE: CORTEXYME, INC.
a Delaware corporation
By: Caryn McDowell
Its: Chief Legal and Administrative Officer
I hereby certify that the signature, name, and title above
are my signature, name and title